These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8537280)

  • 1. Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli.
    Harnett N; McLeod S; Yong YA; Hewitt C; Vearncombe M; Krishnan C
    J Antimicrob Chemother; 1995 Jul; 36(1):269-70. PubMed ID: 8537280
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to quinolones among Campylobacter species--Ontario.
    Preston MA; Brown S; Borczyk A
    Can Commun Dis Rep; 1995 Sep; 21(17):156-60. PubMed ID: 7581214
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
    Rautelin H; Renkonen OV; Kosunen TU
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2065-9. PubMed ID: 1759828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level.
    Pedersen K; Wedderkopp A
    J Appl Microbiol; 2003; 94(1):111-9. PubMed ID: 12492931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011-2013.
    Riley A; Eshaghi A; Olsha R; Allen VG; Patel SN
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):292-4. PubMed ID: 26320936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
    Engberg J; Aarestrup FM; Taylor DE; Gerner-Smidt P; Nachamkin I
    Emerg Infect Dis; 2001; 7(1):24-34. PubMed ID: 11266291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
    Obana M; Matsuoka Y; Irimajiri S; Tonooka H
    Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics.
    Endtz HP; Broeren M; Mouton RP
    Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):48-50. PubMed ID: 8462563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.
    Krausse R; Ullmann U
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2946-50. PubMed ID: 12936999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli human isolates from Bosnia and Herzegovina.
    Uzunovic-Kamberovic S
    J Antimicrob Chemother; 2003 Apr; 51(4):1049-51. PubMed ID: 12654755
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.
    Sjögren E; Kaijser B; Werner M
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2847-9. PubMed ID: 1482158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone susceptibility of Campylobacter strains, Senegal.
    Cardinale E; Dromigny JA; Tall F; Ndiaye M; Konte M; Perrier-Gros-Claude JD
    Emerg Infect Dis; 2003 Nov; 9(11):1479-81. PubMed ID: 14718098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates.
    Ruiz J; Goñi P; Marco F; Gallardo F; Mirelis B; Jimenez De Anta T; Vila J
    Microbiol Immunol; 1998; 42(3):223-6. PubMed ID: 9580533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production.
    Pérez-Boto D; García-Peña FJ; Abad-Moreno JC; Echeita MA
    Microb Drug Resist; 2013 Aug; 19(4):323-30. PubMed ID: 23391315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
    Wardak S; Szych J; Zasada AA; Gierczynski R
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1123-5. PubMed ID: 17210776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Salmonella and Campylobacter species to antimicrobial agents.
    Mirelis B; Llovet T; Muñoz C; Navarro F; Prats G
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):312. PubMed ID: 10385026
    [No Abstract]   [Full Text] [Related]  

  • 17. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
    Smith KE; Besser JM; Hedberg CW; Leano FT; Bender JB; Wicklund JH; Johnson BP; Moore KA; Osterholm MT
    N Engl J Med; 1999 May; 340(20):1525-32. PubMed ID: 10332013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli from poultry in Italy.
    Giacomelli M; Salata C; Martini M; Montesissa C; Piccirillo A
    Microb Drug Resist; 2014 Apr; 20(2):181-8. PubMed ID: 24320689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
    Hänninen ML; Hannula M
    J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.
    Engberg J; Neimann J; Nielsen EM; Aerestrup FM; Fussing V
    Emerg Infect Dis; 2004 Jun; 10(6):1056-63. PubMed ID: 15207057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.